Tg Therapeutics (TGTX) Revenue (2017 - 2026)
Tg Therapeutics (TGTX) recorded Revenue of $240.34 million in Q2 2026, up 70.3% from $141.15 million a year earlier and up 17.3% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Revenue (2017 - 2026) Analysis & Trends
On a TTM basis, Tg Therapeutics' Revenue came in at $799.54 million as of Jun 30, 2026, up 76.1% year-over-year; for FY2025, it was $616.29 million, up 87.3% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 426.7% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $329 million in FY2024 (+40.8%), $233.66 million in FY2023, $2.79 million in FY2022 (-58.4%) and $6.69 million in FY2021.
- The Q2 2026 figure is the highest quarterly Revenue in data going back to Q2 2017.
- On a year-over-year basis, Revenue has increased for seven consecutive quarters, with growth averaging 73.7% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 713.5% in Q1 2024, against a decline of 96.6% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $204.92 million (Q1 2026), $192.57 million (Q4 2025) and $161.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Tg Therapeutics | 8.54 Bn | 7.93 Bn | 199.14 Mn | 240.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.34 Mn |
| Mar 31, 2026 | 204.92 Mn |
| Dec 31, 2025 | 192.57 Mn |
| Sep 30, 2025 | 161.71 Mn |
| Jun 30, 2025 | 141.15 Mn |
| Mar 31, 2025 | 120.86 Mn |
| Dec 31, 2024 | 108.19 Mn |
| Sep 30, 2024 | 83.88 Mn |
| Jun 30, 2024 | 73.47 Mn |
| Mar 31, 2024 | 63.47 Mn |
| Dec 31, 2023 | 43.97 Mn |
| Sep 30, 2023 | 165.82 Mn |
| Jun 30, 2023 | 16.07 Mn |
| Mar 31, 2023 | 7.80 Mn |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 594,000.00 |
| Mar 31, 2022 | 2.02 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 2.03 Mn |
API Access
Tg Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();